Global Non-invasive Prenatal Genetic Screening Test Kits Market Growth 2025-2031

The global Non-invasive Prenatal Genetic Screening Test Kits market size is predicted to grow from US$ 295 million in 2025 to US$ 407 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

United States market for Non-invasive Prenatal Genetic Screening Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Non-invasive Prenatal Genetic Screening Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Non-invasive Prenatal Genetic Screening Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Non-invasive Prenatal Genetic Screening Test Kits players cover Illumina, Thermo Fisher Scientific, Progenity, Intergrated Genetics, BGI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Prenatal Genetic Screening Test Kits Industry Forecast” looks at past sales and reviews total world Non-invasive Prenatal Genetic Screening Test Kits sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-invasive Prenatal Genetic Screening Test Kits sales for 2025 through 2031. With Non-invasive Prenatal Genetic Screening Test Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Prenatal Genetic Screening Test Kits industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Prenatal Genetic Screening Test Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Prenatal Genetic Screening Test Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Prenatal Genetic Screening Test Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Prenatal Genetic Screening Test Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Prenatal Genetic Screening Test Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Prenatal Genetic Screening Test Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Single Molecule Sequencing
Nanopore Sequencing

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Progenity
Intergrated Genetics
BGI
Novogene

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-invasive Prenatal Genetic Screening Test Kits market?

What factors are driving Non-invasive Prenatal Genetic Screening Test Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-invasive Prenatal Genetic Screening Test Kits market opportunities vary by end market size?

How does Non-invasive Prenatal Genetic Screening Test Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.